The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Clinical trial NCT06342323 · UNKNOWN

Trial details

NCT number: NCT06342323
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Lung Cancer Liver Cancer Pancreatic Cancer Renal Cell Carcinoma

Start date: 2023-10-08
Primary completion: 2024-10-07
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.